Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain or spinal cord.
EXCLUSIVE: Statera Biopharma CEO Says Mgmt. Wants To Improve Pipeline In Both Depth And Breadth
https://www.youtube.com/watch?v=qC7AjBJOhxk
EXCLUSIVE: Statera CEO Notes Co. Is Well Capitalize, Says Will Be Opportunistic About Who We Acquiring Moving Forward
https://www.youtube.com/watch?v=qC7AjBJOhxk
EXCLUSIVE: Statera Biopharma CEO Begins Interview On Benzinga’s ‘Power Hour’ YouTube Show
https://www.youtube.com/watch?v=qC7AjBJOhxk
What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
Photo by ThisisEngineering RAEng on Unsplash
72 Biggest Movers From Yesterday
Gainers
Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
Statera BioPharma: The Ticker Formerly Known as CBLI
On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.